GL Pharm Tech Corp. (KOSDAQ:204840)
1,045.00
+14.00 (1.36%)
At close: Jan 23, 2026
GL Pharm Tech Revenue
GL Pharm Tech had revenue of 9.53B KRW in the quarter ending September 30, 2025, with 103.71% growth. This brings the company's revenue in the last twelve months to 34.30B, up 37.75% year-over-year. In the year 2024, GL Pharm Tech had annual revenue of 26.05B with 0.06% growth.
Revenue (ttm)
34.30B
Revenue Growth
+37.75%
P/S Ratio
2.36
Revenue / Employee
1.04B
Employees
33
Market Cap
81.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.05B | 14.93M | 0.06% |
| Dec 31, 2023 | 26.03B | 9.30B | 55.62% |
| Dec 31, 2022 | 16.73B | 4.30B | 34.63% |
| Dec 31, 2021 | 12.43B | 437.53M | 3.65% |
| Dec 31, 2020 | 11.99B | 1.38B | 13.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahn-Gook Pharmaceutical | 300.96B |
| Cosmax Nbt | 293.75B |
| H.PIO | 257.56B |
| Daehan Nupharm | 201.59B |
| Jin Yang Pharmaceutical | 117.19B |
| Sinsin Pharmaceutical | 110.29B |
| Hwail Pharmaceutical | 107.87B |
| Sinil Pharmaceutical | 80.97B |